Anisopappus chinensis
Anisopappus chinensis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Anisopappus chinensis is a botanical species that has garnered significant scientific interest due to its diverse pharmacological properties. Research indicates that this plant possesses notable antiplasmodial and cytotoxic activities, making it a subject of study for medicinal applications. These biological effects are largely attributed to the presence of essential chemical compounds such as flavonoids and terpenes. Such characteristics suggest a potential role for the plant in developing treatments for serious medical conditions, including malaria. Consequently, exploring the chemical profile of this species remains a priority for advancing natural drug discovery.
- Synonyms
- Inula Yunnanensis · Verbesina Chinensis · 4 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Anisopappus chinensis is a fascinating plant known by several distinct names across different linguistic traditions. In certain regions, it is locally referred to by the common name visakultakehrä. When looking toward East Asian contexts, the species is widely recognized as 山黃菊. This name is also frequently written using traditional characters as 山黄菊 to denote its identity. These various designations highlight the diverse cultural and geographical ways in which this botanical species is identified.
Sources: Catalogue of Life (COL)
Synonyms
Anisopappus chinensis is a botanical species characterized by a complex web of taxonomic synonyms. Throughout various scientific records, it has been identified by the name Anisopappus candelabrum. The plant is also documented under the synonym Chrysogonum philippinense, highlighting potential shifts in classification over time. Furthermore, researchers have previously referred to this species as Epallage dissitifolia or Inula yunnanensis. Finally, the nomenclature includes Myriactis candelabrum, illustrating the diverse naming history associated with this plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Anisopappus chinensis is a distinctive member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. It belongs to the specific genus Anisopappus, which defines its unique structural characteristics. This plant is further categorized under the order Asterales to show its evolutionary connections. Finally, it is a prominent representative of the diverse family Asteraceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Anisopappus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Anisopappus chinensis exhibits a diverse geographical range that spans across several distinct regions of Asia. In temperate zones, the species is widely distributed throughout various parts of China, including the South-Central and Southeast provinces. Its presence extends into tropical climates, where it can be found across the Indian Subcontinent in areas such as Assam and the East Himalaya. Additionally, the plant thrives within the Indo-China region, specifically documented in Cambodia. This broad distribution highlights the plant's ability to adapt to both temperate and tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Anisopappus chinensis is a self-supporting herb that grows independently in its natural habitat. This botanical species exhibits a versatile growth form, characterized by its sturdy, upright structure. Depending on environmental conditions, the plant typically reaches a minimum height of 0.4 meters. In more optimal settings, it can develop significantly more, often attaining a height of at least 1.5 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Anisopappus chinensis has demonstrated significant biological potential through its dual antiplasmodial and cytotoxic activities. Research involving Congolese medicinal plants revealed that the whole plant extracts, specifically methanolic and dichloromethane preparations, possess high antiplasmodial potency. These extracts were effective in inhibiting the growth of both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Furthermore, the plant showed promising in vivo results by successfully inhibiting parasitemia in mice models. Notably, Anisopappus chinensis also exhibited a favorable selectivity index, suggesting it may be effective against parasites while remaining relatively safe for human cells.
Compounds
Anisopappus chinensis is a significant plant species identified in studies regarding Congolese traditional medicine for malaria treatment. Through general phytochemical screening methods, researchers have successfully identified key chemical constituents within the plant. Specifically, the analysis confirmed that Anisopappus chinensis contains flavonoids and terpenes. These compounds contribute to the plant's high antiplasmodial activity and its ability to inhibit parasitemia in vivo. Furthermore, the presence of these phytochemicals supports the plant's potential as a medicinal resource with a favorable selectivity index.
Conditions
Anisopappus chinensis is recognized for its potential to treat malaria through its demonstrated antiplasmodial activity. Research involving extracts from the whole plant showed high inhibitory activity against Plasmodium falciparum strains in vitro. Beyond laboratory testing, the plant also exhibited a good inhibition of parasitemia during in vivo studies in mice. Furthermore, Anisopappus chinensis demonstrated a favorable selectivity index of greater than 10, indicating its effectiveness against parasites relative to human cells. These findings support its traditional use as a medicinal plant for combating malaria.